---
title: "Cochlear  (CHEOF) Gets a Hold from Macquarie"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301347426.md"
description: "Macquarie analyst maintained a Hold rating on Cochlear today and set a price target of A$124.00. In a report released on October 1, Morgan Stanley also maintained a Hold rating on the stock with a A$133.00 price target."
datetime: "2026-10-09T03:05:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301347426.md)
  - [en](https://longbridge.com/en/news/301347426.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301347426.md)
generator: "portal-rs"
---

# Cochlear  (CHEOF) Gets a Hold from Macquarie

Macquarie analyst maintained a Hold rating on Cochlear today and set a price target of A$124.00.

In a report released on October 1, Morgan Stanley also maintained a Hold rating on the stock with a A$133.00 price target.

### Related Stocks

- [CHEOY.US](https://longbridge.com/en/quote/CHEOY.US.md)
- [COH.AU](https://longbridge.com/en/quote/COH.AU.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)

## Related News & Research

- [UBS Keeps Their Hold Rating on Cochlear  (CHEOF)](https://longbridge.com/en/news/302231742.md)
- [Cochlear® Nucleus® Nexa® System Named One of TIME's Best Inventions of 2026](https://longbridge.com/en/news/302415256.md)
- [Macquarie Sticks to Its Hold Rating for Cochlear  (CHEOF)](https://longbridge.com/en/news/300498716.md)
- [Citi Keeps Their Hold Rating on Cochlear  (CHEOF)](https://longbridge.com/en/news/298516761.md)
- [Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026](https://longbridge.com/en/news/301862137.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**